These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2947248)

  • 21. [Peptid contraception--new principles for family planning].
    Nillius SJ
    Lakartidningen; 1981 Aug; 78(34):2845-8. PubMed ID: 7033692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pros and cons of triphasic oral contraception].
    Berdah J
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
    Lemay A; Labrie F; Raynaud JP
    Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-cycle contraception with LHRH in women.
    Maia H; Barbosa IC; Maia H; Coutinho EM
    Reproduccion; 1981; 5(4):251-60. PubMed ID: 7033017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The possible use of antiprogestins for contraception.
    Bygdeman M; Danielsson KG; Swahn ML
    Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).
    Schriock E; Monroe SE; Henzl M; Jaffe RB
    Fertil Steril; 1985 Nov; 44(5):583-8. PubMed ID: 2932349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys.
    Navot D; Rosenwaks Z; Anderson F; Hodgen GD
    Fertil Steril; 1991 Jun; 55(6):1069-75. PubMed ID: 1828042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled delivery of a GnRH agonist by a silastic implant (Gonazon) results in long-term contraception in queens.
    Rubion S; Driancourt MA
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():79-82. PubMed ID: 19754541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
    Bergquist C; Nillius SJ; Wide L
    Lancet; 1979 Aug; 2(8136):215-7. PubMed ID: 89330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of GnRH antagonist on the endometrium of normally menstruating women.
    Sirayapiwat P; Suwajanakorn S; Triratanachat S; Niruthisard S
    J Assist Reprod Genet; 2007 Dec; 24(12):579-86. PubMed ID: 18049889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GnRH analogues in the treatment of endometriosis.
    Erickson LD; Ory SJ
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.
    Johansen JS; Riis BJ; Hassager C; Moen M; Jacobson J; Christiansen C
    J Clin Endocrinol Metab; 1988 Oct; 67(4):701-6. PubMed ID: 2971080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GnRH analogs in gynecology. Possibilities for therapeutic use].
    Niesert S
    Fortschr Med; 1990 Sep; 108(26):498-500. PubMed ID: 2262188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nafarelin: a new medical therapy for endometriosis.
    Henzl MR; Monroe SE
    Prog Clin Biol Res; 1990; 323():343-55. PubMed ID: 2137620
    [No Abstract]   [Full Text] [Related]  

  • 36. GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects.
    Vega RR; Barraza-Vázquez A; Vega MG; Fernández-González EM; Mayagoitia SB
    Adv Contracept; 1996 Mar; 12(1):15-25. PubMed ID: 8739513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of peptides for contraception].
    Korkhov VV
    Akush Ginekol (Mosk); 1987 Sep; (9):9-10. PubMed ID: 3322081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    Riis BJ; Christiansen C; Johansen JS; Jacobson J
    J Clin Endocrinol Metab; 1990 Apr; 70(4):920-4. PubMed ID: 2138631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological studies of human endometrium during continuous LH-RH agonist treatment.
    Lundkvist O; Bergquist C
    Int J Fertil; 1986; 30(4):65-70. PubMed ID: 2890599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience in the use of nafarelin for treatment of benign breast disease.
    Roberts JV
    Br J Clin Pract Suppl; 1989 Nov; 68():37-42; discussion 49-53. PubMed ID: 2535115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.